Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER ...

As the United States heads into the colder weather months, cases of respiratory syncytial virus (RSV) have been ticking up across the country. For the week ending Nov. 25, there were 8,863 positive ...

Respiratory syncytial virus (RSV) is a common virus that affects the throat, nose, and lungs. Symptoms include a runny nose, congestion, sneezing, wheezing, cough, and fever, and these are often mild ...

Add Yahoo as a preferred source to see more of our stories on Google. Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being ...

NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...

Respiratory viruses are usually most active from October through March, health officials say.

Older adults in England are being urged by health officials to get vaccinated against respiratory syncytial virus (RSV). More than one million people aged 75 to 79, or those turning 80 after September ...

CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The ...

Health officials are urging residents to take preventive steps such as vaccination, handwashing and staying home when sick.

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...